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The  factors which  influence  the  severity of a  virus  infection,  other  than 
dosage and virulence of the virus,  and  specific immunity of the host,  are at 
best but poorly understood. Evidence has been presented  (1)  that pneumonia 
virus of mice (PVM)  or an antigenically similar agent may cause latent infec- 
tion in a  variety of animal species. Furthermore,  it has been shown that the 
severity of this infection in mice is influenced by the strain of mouse employed 
(2), the age of the mouse (3), and the diet which it is fed before (4) and during 
(5)  the period of infection. 
In 1943 Nettleship, Henshaw, and Meyer (6)  reported that urethane stimu- 
lated the development of pulmonary adenomas in susceptible strains of mice. 
This phenomenon was confirmed by Jaff6 (7) and has been extensively studied 
in mice and rats by others (8-14). Because of this extraordinary effect on lung 
tissues,  it seemed of interest  to determine the influence of urethane on infec- 
tion  with  the  strictly  pneumotropic  virus  PVM.  The  enhancing  effect  of 
urethane on the  severity of this virus infection has been reported previously 
in abstract  (15)  and is more completely described below. 
Materials  and Methods 
M~e.--Albino  Swiss mice used in all the experiments with PVM were obtained from a 
commercial breeder, Mrs. Flora O'Grady. In some experiments concerning tumor develop- 
ment, strain A mice were employed. These were from our own breeding colony of mice origi- 
nally obtained from the National Cancer Institute through the courtesy of Dr. C. D. Larsen. 
All mice were caged in glass jars on pine shavings, fed Purina dog chow, and given water to 
drink. Unless otherwise stated, the mice weighed approximately 10 grn. each at the time of 
infection with PVM. 
Virus.--Pueumonia virus of mice, strain No. 15, was originally obtained from Dr. Frank 
L. Horafall, Jr., and maintained by occasional intranasal passage in susceptible young mice. 
Infective extracts of the lungs were stored in a dry-ice chest. 
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Virus Titrations.--The technique for measuring the infectivity titer of virus was similar 
to that employed by Horsfall and Cumen (16) and has been described in detail elsewhere 
(5). The methods  for performing hemagglutination  and hemagglutination  inhibition  tests 
were identical with those described by Curnen and Horsfall (17). 
In some experiments the immunity  of individual mice was determined by a microtechnique 
(18). Heparinized tail blood of the test mouse was mixed in a capillary tube with an equal 
volume of heated mouse lung extract containing four or more hemagglutinating units of PVM. 
The absence of erythrocyte agglutination indicated the presence of antibody  in the test plasma. 
Urethane.--Ethyl urethane (Merck and Co.) was employed throughout.  Solutions were 
made in distilled water and stored in dark bottles at room temperature. 
EXPERIMIENTAL 
Effect  of Parenteral  Urethanc  on" PVM  Infection.--The  effect  of  a  single 
parenteral injection of urethane the day before infection with PVM was tested 
in nine experiments. 
Duplicate  fitrations  of virus were made in two comparable groups of 20 mice, one of 
which received urethane while the other served as control, using a total of 300 mice. It was 
found that the intraperitoneal injection of 0.5 mg./gm, into 10 gm. mice  resulted in slight and 
irregular stimulation of the infection. This is half the amount used by Nettleship eta/. (6) 
in larger mice to stimulate tumor formation. With larger doses the effect on PVM was some- 
what more marked. The 50 per cent maximum lesion score (M.S.50) in mice, each of which had 
received 2 mg./gm, the day before injection, was 0.97 log units higher than in controls. Un- 
infected mice given 3 mg./gm, or more of urethane died within a day or two of the injection 
and the lungs appeared hemorrhagic in the gross. However, uninfected mice, given 2 mg./gm. 
or less had lungs that were normal in the gross at the end of the 12 day experimental period 
used for testing PVM infection. 
Effect of Intranasal  Urethane  on PVM Infection.--The  effect of  intranasal 
urethane was tested in 3 experiments. 
0.05 cc. of urethane  10 per cent in water was inoculated intomice on the day after PVM 
was titered. The M.S.50 was slightly greater (average 0.48 log) in each instance in the mice 
which had received urethane. 
Effect  of  Oral  Uretltane  on  PVM  Infection.--Since  urethane  is  excreted 
very rapidly, the majority of it in 24 hours  (19),  it was decided  to  test its 
effects when given in the drinking water throughout the entire 12 day experi- 
mental period. The virus titers observed in 27 experiments in mice receiving 
from 0.1 to 0.5 per cent urethane to drink are shown in Table I. It will be seen 
that the M.S.50 titers in the urethanized mice were consistently higher than 
in the controls. Moreover, as shown in Fig. 1, the increased titers observed vary 
directly with the concentration of urethane administered. It will be shown sub- 
sequently (Table IV) that the mice given 0.5 per cent urethane to drink actually 
ingested about twice as much of the drug as those given 0.1 per cent. 
The  Duration  of  Urethane  Ingestion  in Reference  to PVM  Infection.--The 
effect  of  urethane  when  drunk  for  varying periods  before  and  after  PVM 
inoculation was tested in a total of 23 experiments. MIRICK~  SMITH~ LEFTWICH~ AND  LEFTWICH 
TABLE  I 
The Effect of Oral  Urethane  on P VM Infection 
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No. of 
experiment 
Urethane 
Concentration in 
drinking water 
per ¢$nI 
0.I 
0.I 
0.I 
0.1 
0.1 
0.I 
0.1 
M.S.50 
/og 
2.00 
2.43 
4.13 
3.38 
3.22 
3.50 
3.39 
Control 
M.S.50 
log 
1.11 
<2.00 
3.19 
3.46 
2.46 
<2.00 
3.29 
Difference 
urethane from control 
log 
+0.89 
> +0.43 
+0.93 
-0.08 
+0.76 
>+1.50 
+0.10 
Average  ....................................................... 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
>+0.52 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
3.34 
3.62 
5.00 
4.88 
3.30 
4.07 
>5.00 
4.59 
4.51 
4.83 
>5.00 
3.29 
2.54 
3.81 
3.81 
2.73 
3.93 
4.36 
4.41 
4.24 
4.24 
3.90 
+0.05 
+1.08 
+1.19 
+1.07 
+0.57 
t0.14 
>+0.64 
+0.18 
+0.27 
tO. 59 
>+1.10 
Average  ....................................................... 
19 
20 
21 
22 
23 
0.3 
0.3 
0.3 
0.3 
0.3 
4.05 
3.91 
>5.00 
>4.00 
>5.00 
3.59 
3.29 
2.91 
3.11 
3.78 
>+0.63 
+0.46 
t0.62 
>+2.09 
> +0.89 
>+1.22 
Average  ....................................................... 
24 
25 
26 
27 
0.4 
0.5 
0.5 
0.5 
4.29 
4.62 
5.80 
4.73 
2.73 
2.46 
<2.00 
2.63 
>+1.06 
+1.56 
+2.16 
>+3.80 
+2.10 
Average  .......................................................  >+2.69 
Duplicate titrations of virus in two similar groups of mice were done in the usual fashion. 
The control groups were given water to drink  throughout the entire experimental period. 
The other groups were given urethane 0.2 per cent to drink starting from the 4th day before ol 
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FIG.  2.  Relation  of  the  time  and  duration  of urethane  ingestion  to its enhancing  effect 
on PVM infection. Urethane 0.2 per cent was given the mice to drink on the day indicated 
and continued for the entire 12 day experimental period after PVM inoculation. 
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virus inoculation until the 4th day after. The differences between the M.S.50 tltem in the 
urethanized mice from the control are plotted in Fig. 2. 
It will be seen that, within the limits tested, the observed lesion scores varied 
directly with the duration of urethane ingestion. When urethane was given 4 
days or more after virus inoculation, no effect was noted. 
Effect  of  Uretkane  on the  Lungs  of  Uninfected  Mice.mControl  mice which 
received the higher concentrations of urethane to drink  (0.4  to 0.5  per cent), 
but which were not inoculated with virus, frequently died during the  12 day 
experimental period. At autopsy their lungs appeared edematous in the gross 
TABLE II 
Effect of Oral Urethane on the Titer of PVM (Experiment 27) 
Urethane  Control 
(0.5 per cent in drinking water)  (given water as such) 
D8*  D8  D8 
++++  ~-+++i++++ 
D9 
+++ 
D7 
++++ 
D12 
++++ 
D10 
~-+++ 
Dll 
~-+++ 
$12 
+++ 
D10 
+++ 
D12 
++++ 
$12 
+ 
D10 
++++ 
D10 
+++ 
$12 
+ 
$12 
0 
D8 
++++ 
S12 
+ 
S12 
+ 
S12 
0 
D8  D9 
++++  ++++ 
S12  S12 
++  ++ 
S12  S12 
0  0 
$12  $12 
0  0 
M.S.50  10-  4"u  10  "~.6s 
Dilution 
of PVM 
0.05 co. 
intrsnamlly 
S12  10  ~ 
++ 
$12  10-  s 
+ 
$12  10  -4 
0 
$12  10-  6 
0 
D signifies death. 
S signifies sacrifice. 
* Number indicates the day following  virus inoculation. 
0 to ++-b+ indicates extent of consolidation. 
with fluid running from the bronchi or cut surfaces. Moreover, the lungs often 
showed patches of plum colored consolidation which, on standing, resembled 
in  the  gross  infection  with  PVM.  In  fresh  specimens  the  lesions  could  be 
differentiated  from PVM  pneumonia  by  the  greater  prominence of  the  en- 
gorged superficial pulmonary vessels in the urethanized mice. 
It is not believed that a  simple summation of two indistinguishable lesions 
will  account for the increased virus titers observed in urethanized mice since 
the drinking of lesser concentrations of urethane  (0.1 to 0.3 per cent), which 
did not cause death or result  in gross changes in  the  lungs of control mice, 
had  enhancing  effects  on  the  lesion  score.  Moreover,  the  death  of  infected 
mice given 0.5 per cent urethane to drink obviously bore a  time relationship 152  EFFECT  OF  URETHANE  ON  PNEUMONIA  VIRUS 
to the amount of virus inoculated, as is shown in Table II. Finally, as described 
below, more virus was present  in the lungs of infected urethanized  mice  than 
in controls. 
Nettleship  et  al.  (6),  Orr  (10),  and  Cowen  (11)  have all  remarked  on  the 
monocytic inflammatory lesions observed in the lungs of mice 8 or more weeks 
after the weekly injection of urethane,  1 mg./gm. These observations in addi- 
tion to our own findings suggested  that  urethane  administration  might have 
resulted,  in  some  unknown  manner,  in  the  activation  of latent  PVM.  This 
possibility  seems  to be eliminated  since  lung extracts  from  uninfected mice, 
dying after the ingestion of 0.5 per cent urethane,  did not produce pneumonia 
when  inoculated  intranasally  into  susceptible  young mice.  Moreover,  heated 
extracts  of  the  lungs  from  uninfected  urethanized  mice  did  not  cause  the 
agglutination  of  mouse  erythrocytes.  And,  finally,  the  intranasal  or  intra- 
TABLE III 
Virus Titers in the Lungs of Mice Drinking Water Containing Urethane 
Day after 
VirUs  inOCU- 
lation 10-1 
6 
7 
8 
9 
Experiment 1  Experiment 2 
Hemagglutinating titer (reciprocal)  Infective titer log M.S.50 
Urethane  Urethane 
64 
256 
256 
32 
0.I per cent 
128 
512 
512 
128 
0.5 per cent 
512 
1024 
1024 
Dead 
0  0.1  per cent 
2.34  2.88 
3.18  3..50 
0.5 per cent 
3.08 
4.47 
Dead 
peritoneal  inoculation  of immune  anti-PVM  rabbit  serum,  in  amounts  suffi- 
cient to completely protect  the mice against  PVM  infection,  did not protect 
them  against  death  with  pulmonary  congestion  and  consolidation  after  the 
ingestion of 0.5 per cent urethane. 
Effect of Urethane on  PVM  Titer in Lung.--All  the observations described 
above, and summarized in Table I  and II and Fig.  1, concern the lesion score 
in the lungs of mice infected with PVM. It seemed important to know whether 
urethane  enhanced  only the  inflammatory  reaction  resulting  from  the  virus 
infection, or whether virus growth was affected also. 
To test this point 48 mice were inoculated intranaeally with 0.05 cc. each of a  10  -s dilution 
of PVM.  Sixteen of the mice were given water  to drink,  16 urethane  0.1 per cent, and the 
remaining 16 urethane 0.5 per cent. On the 6th, 7th, 8th, and 9th days after virus inoculation, 
4 mice from each group were sacrificed, their lungs pooled separately  and extracted  in the 
usual fashion. The amount of virus in these extracts was determined both by its infectivity 
titer and its hemaggiutinating  titer after heating. The results are recorded in Table III and 
Fig. 3. It will be seen that the highest virus titers in each group were present on the 7th and 
8th days after  inoculation  and  increased with  the amount of urethane  ingested.  All mice MIRICK,  SMITH, LEFTWqCH,  AND  LE~FTWICH  153 
receiving 0.5  per cent urethane to drink had died before the 9th day so no determinations 
could be made on that day. 
In a second similar experiment, also shown in Fig. 2, the hemagglutinating titers of heated 
lung extracts from urethanized and control mice were determined on days 2,  3,  4,  5,  6,  7, 
and 8 after virus infection. It was found in each group that virus, measurable by this tech- 
nique, appeared on the 4th day after inoculation. The titer was always higher in the urethan- 
ized mice. As in the first experiment, all these mice died before the 9th day when the maxi- 
mum virus titer was measured, whereas in the control group the titer had commenced to fall 
by  that  time. 
It is  concluded that  urethane not  only causes  an increased lesion titer in 
PVM  infection but  also  causes  increased  multiplication  of  the  virus.  Some 
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per cent urethane: a  composite of 2 experiments. 
or containing 0.5 
experiments were planned in an attempt to elucidate the mechanism of these 
effects. 
Effects of Urethane on Fluid Consumption and Weight Gain of M/ce.mUrethane 
is a  narcotic in  doses of  1 mg./gm,  and greater.  Following the  single  intra- 
peritoneal injection of half this dose into  10 gm. mice, they were somnolent 
for about 1/~ hour but then recovered and behaved normally, eating,  drinking, 
and  gaining  weight  like controls.  When  given  increasing  concentrations  of 
urethane from 0.1  to 0.5 per cent to drink ad libitum, there was a progressive 
decrease in fluid consumption and in weight gain.  In Table IV are recorded 
the measured fluid and urethane intake and weight changes in groups of mice 
observed over a 12 day period corresponding to the one usually used for study- 
ing PVM  infection. It can be seen that  control mice gained an average of 9 154  EFFECT  OF  URETHANE  ON  PNEUMONIA  VIRUS 
gm. over the 12 day period and drank on the average of 0.51  cc. of water per 
gin. per day. Those which received a  single injection of urethane or drank 0.1 
per cent urethane  behaved much as  the  controls. Mice  given 0.2  to 0.3  per 
cent urethane  to drink  gained only about  1 gin.  in weight and drank about 
half as much fluid as the controls. Those given 0.5 per cent urethane actually 
lost 0.8  gin.  in weight and drank  only 0.17  cc.  per gm. per day.  Data  con- 
cerning mice given a  synthetic  diet  containing  4  per  cent protein  (5),  such 
that  their  weight  remained  approximately  constant,  and  other  mice  given 
water  limited  to  the  amount  ingested  by mice drinking  0.2  to  0.3  per  cent 
urethane ad libitum, are also recorded in Table IV. 
TABLE IV 
E.gects of Urethane on Growth and Water Consumption of Young Mice 
~0. of 
mice 
16 
8 
4 
4 
4 
4 
4 
4 
Urethane 
0 (Control) 
0.5 reg./gin, intraperito~eally on day 1 
0.1 per cent in drinking water 
0.2 per cent in drinking water 
0.3 per cent in drinking water 
0.5 per cent in drinking water 
0* 
0~ 
Average weight 
Day1  Day 12'  Gain 
gm.  gm.  gm. 
9.6  18.6  9.0 
9.4  18.1  8.7 
10.0  18.9  8.9 
10.5  11.5  1.0 
10.0  11.2  1.2 
9.7  8.9  0.8 
10.4  10.9  0.5 
9.7  16.0  6.3 
Average water  Averag  ure~ 
consumed  thane 
c~./  ¢c./gm./  rag.~ 
d~y 
7.2  0.51 
8.2  0.60  0.50 
6.2  0.43  0.43 
2.5  0.23  0.46 
2.9  0.27  0.81 
1.6  0.17  0.85 
11.0  1.00 
3.2  0.25 
* Synthetic diet containing 4 per cent protein. 
Water limited to 3.2 cc./mouse/day. 
It seemed possible that  simple limitation of growth  or fluid  intake  might 
account  for  the  changes  in  susceptibility  to  PVM  noted  in  mice  receiving 
urethane. It has been shown previously (5) that mice receiving the 4 per cent 
protein  diet were  equally  susceptible  to  PVlVl as controls.  It is possible,  of 
course,  that urethane  intoxication may result  in  some other deficiency than 
limited protein. However, most acute deficiencies studied  (4,  5)  have,  unlike 
the  urethane  effect,  resulted  in  decreased  susceptibility of the  host  to  viral 
infections. 
Sprunt (20) has reported that dehydration resulted in increased susceptibility 
of rabbits to infection with vaccinia virus. However, when duplicate titrations 
of PVM were done in mice receiving water limited to 2.5 to 3.0 cc./mouse/day, 
no differences in titers were found from those in control mice given unlimited 
water to drink. 
Effects  of Urethane  on Lung Weights.--It was noted above that the lungs of MIRICK,  SMITH,  LEFTWICH,  AND  LEFTWICH  155 
mice given the larger concentrations of urethane seemed congested and edema- 
tous. In 1922 Carrier (21) reported that the injection of urethane into human 
skin resulted in dilatation of both capillaries and arterioles. L6hr (22)  found 
that this drug resulted in bronchodilatation and a marked vascular expansion 
in  the  lung.  Winchester  and  Higgins  (23)  observed  pulmonary  edema  in 
leukemic mice following treatment  with  urethane,  and  Rosin  (14)  observed 
similar changes in rats.  To quantitate  our observations the lungs of normal 
mice, of mice given various concentrations  of urethane to drink, and of others 
fed a  synthetic diet containing 4  per cent protein, were  weighed at the end 
of 12 days. These weights and their relation to total body weight are recorded 
in Table V. It will be seen that the  relationship of lung weight to body weight 
TABLE V 
gffea of Urethane on the Weights of Lung, Spleen, and Thymus* 
No. of  Urethane drunk  mice 
4  0  (Control) 
4  O. 1 per cent 
4  0.3 per cent 
4  O. 5 per cent 
8  O§ 
Average weight at 12 days 
Lung  Thymus 
Total 
gm. 
21.8 
18.9 
11.2 
8.9 
11.2 
Per ce~ 
of tota 
211  0.97 
201  1.06 
200  1.79 
207  2.33 
120  1.07  t 
Spleen 
Per cent 
of total 
T 
101 
6O 
9 
25 
0.46  50  g 
0.32 
0.08 
--  8.4 
0.22 
Per cent 
of total 
0.23 
0.01 
* Mice each weighed 9.6 to 10 gm. at beginning 
drink for 12 days when they were sacrificed. 
Minute. 
§ Diet contained 4 per cent protein. 
of experiment and received urethane to 
was progressively greater in the mice given increasing  amounts of urethane. 
These observations can be taken to support our impression that the lungs of 
urethanized mice became edematous and congested. The possible relation of 
these changes to the effects of urethane on PVM  infection will be discussed 
subsequently. 
Effects  of Urethane  on Lymphoid Tissues.--In additiod to the gross changes 
in the lungs described above it was noted that the spleens and thymus glands 
of mice which had received urethane were smaller than in controls. Murphy and 
Sturm  (24)  had previously described the atrophy of lymphoid tissues in rats 
given urethane.  In  Table  V  the  spleen  and  thymus  weights  of mice  given 
various concentrations of urethane to drink for 12 days are recorded, together 
with the lung weights. The thymus glands of mice given 0.5 per cent urethane 
to drink were less than 20 per cent the  size of controls. The spleens were pro- 156  EFFECT  OF  URETH.ANE ON  PNEUMONIA VIRUS 
gressively smaller  in  the  mice  given  increasing  amounts  of  urethane.  This 
reduction in spleen size was considerably greater than could be accounted for 
by simple inanition. 
Effect of Urethane on Antibody Production.--In view of the suppressing effect 
of urethane on lymphatic tissues, it seemed possible that this substance might 
exert  its enhancing  effect  on  PVM  infection by interfering with  the  normal 
immune response. 
To test the point 20 mice, approximately 6 weeks old, were inoculated intranasally with 
0.05 cc. each of a sublethal dilution (10  -'4) of PVM, and 2 days later they were reinoculated 
intraperitoneaily with 0.1 cc. each of an undiluted virus suspension. Half of these mice were 
given 5 rag. each of urethane intraperitoneally on the 1st day of virus inoculation and 0.1 
per cent urethane to drink for the remainder of the experimental period. The other half served 
as controls and received no urethane. Twenty-one days after the virus inoculation the mice 
were bled from the heart and the serum from each group pooled separately. The titer of each 
serum pool which would inhibit 4 hemagglutinating units of virus was tested by the standard 
method and the titers were found to be equal. 
This experiment was repeated with two groups of uninfected mice and the native capacity 
of their sera to inhibit virus hemagglutinafion  was again found to be equal. In another experi- 
ment virus was fitered intranasaUy  in two comparable groups of mice in dilutions from  10  -s 
to 10  -l°. One group was given water to drink and the other urethane 0.5 per cent to drink for 
6 days and then water. Mter 23 days antibody was measured in all surviving mice by the micro 
test described elsewhere (18). The majority of the urethanized mice receiving virus dilutions 
of 10  -5 and 10  -6 died from PVM infection before antibody was measured.  Those receiving 
inocula of 10  -7 and  10-  8 developed a  higher titer of antibody than controls. Moreover,  the 
majority of the urethanized mice inoculated with virus dilutions of 10  -9 and 10  -l° developed 
antibody whereas none of the control mice receiving these higher dilutions of virus developed 
any antibody measurable  by this technique. 
It is concluded that urethanized mice can be infected with smaller amounts 
of virus  than  normal  controls and  that  the  enhancing  effect  of  urethane  on 
PVM infection is not to be explained by a  suppression of the normal immune 
response to this virus. 
Effect  on PVM of Certain Substances  Chemically or Pharmacologically  Related 
to  Urethane.--Larsen  (8)  tested the  activity of a  series of esters of carbamic 
acid, alkylated urethanes, and miscellaneous compounds for oncogenic activity 
and found  them  all inactive or not nearly as active as the parent substance, 
urethane.  Cowen  (25),  using  a  small  series  of  mice,  reported  that  pentose 
nucteotides inhibited the carcinogenic properties of urethane.  We have tested 
a  few  substances  chemically related  to  urethane  for  activity against  PVM. 
These  included urea  0.5  per  cent,  methyl  urethane  0.4  per  cent,  and  uracil 
0.37  per cent,  all administered in the drinking water, and pentose nucleotide 
(Smith, Kline, and French Laboratories) intranasally or by repeated injection. 
None  of  these  substances  seemed  to  exert any  clear  cut  effect  on  the  virus 
infection. 
Certain  interesting  pharmacological  activities of  urethane  have  been  de- 
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arrested mitosis (28), alkalosis (26), and antihistaminic action (29, 30). In view 
of these reports the effects of benzol, colchicine, sodium bicarbonate, and the 
antihistaminic  drug  dramamine  (G.  D.  Searle  and  Co.)  were  all  tested  on 
PVM infection. Since no significant effect was noted in any case details will be 
omitted. 
The Rdation of PVM to Pulmonary Adenomas in  Mice.--The discovery that 
urethane, which causes pulmonary adenomas to appear in mice, also enhances 
PVM  infection  immediately  suggested  that  there  might  be  some  relation 
between the virus and the tumor. 
To test the point  two  strains of  mice were  employed,  the O'Grady  strain used in  this 
laboratory to study PVM infection and strain A mice which are most commonly employed in 
the study of adenomas.  A  variety of observations were  made. 
Both strains of mice proved equally susceptible to PVM infection. At the 
age of 6 months 31.3 per cent of 96 O'Grady mice and  15.1  per cent of 185 
strain A  mice had one or more spontaneous adenomas.  In other mice of the 
same sort given 0.1 per cent urethane to drink for 7 weeks starting at 4 weeks 
qf age, 93.8 and 100 per cent respectively had tumors when they were sacrificed 
at 6 months of age. PVM was recovered in each of two attempts on the 6th 
serial intranasal passage at 6 day intervals of lung extracts of O'Grady mice 
with or without urethane, but was not recovered from strain A mice in either 
of two tries after 12 serial passages.  The intranasal inoculation of tumor ex- 
tracts into each strain did not result in pneumonia resembling PVM infection 
nor in  an  increased incidence of adenomas at  6 months.  Heated extracts of 
adenomatous lungs did not agglutinate mouse erythrocytes. Mice immunized 
intranasally and  intraperitoneally against  PVM developed adenomas almost 
as often as the controls, and immunization with extracts of the tumors did not 
protect mice against  adenoma development or PVM  infection. In individual 
mice there was no correlation between immunity to PVM, as measured by the 
micro test (18)  at 6 months of age, and the presence of pulmonary adenomas. 
Finally, Salmonella  typhosa  extracts which we  have found to  suppress  PVM 
infection (31),  when  inoculated  three  times  at  monthly  intervals,  had  no 
suppressive action on the occurrence of adenomas  at  6 months. It was  con- 
cluded that  the available  evidence  indicated  no  relationship  between  latent 
or  overt  PVM infection and the development of pulmonary adenomas. 
DISCUSSION 
The effects of urethane on bacteria have been widely studied in v~ro. It has been 
shown  to inhibit nitrate reduction by Escherichia  coli  (32), certain dehydrogenase 
systems  of Staphylococcus aureus  (33),  and the respiratory systems  of luminescent 
bacteria (34). Weinstein  and McDonald (35) have described  the bacteriostatic and 
bacteriocidal action of urethane on many species of bacteria. It was found (36) to 
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respiration  to a greater extent than the parent strain. Little has been written on the 
effect of urethane on viruses. Bawden and Pirie  (37) found that it inactivated the 
plant viruses of tobacco mosaic, tomato bushy stunt and potato "X" diseases. Fraser 
el  al.  (38) have shown that the thermal denaturation of tobacco  mosaic virus  is 
accentuated by urethane and Foster el al.  (39) have found that urethane also accel- 
erates the thermal inactivation of bacteriophage. 
In the study of animal viruses the problem is greatly complicated by the effects of 
urethane on many systems of the host.  Burney and Golub (40) found that urethane 
had no effect on psittacosis virus in tissue culture. Favilli (41) found that it inhibited 
infection of the rabbit's skin by vaccinia virus.  Fiala, however, reported  (42) that 
vaccinia  virus,  given intracerebrally  or intravenously,  resulted in both skin lesions 
and fatal encephalitis in rabbits receiving urethane subcutaneously, whereas control 
rabbits  developed no  apparent  lesions or  symptoms from  the  amounts of  virus 
employed. 
Our experiments show that urethane enhances the severity of the pulmonary 
infection of mice caused by PVM and leads to increased multiplication of the 
virus. A decrease of lymphoid tissues was observed in urethanized mice but 
the drug did not seem to impair the production of antibody. The mechanism 
of its action on PVM is unknown but may be related to the pulmonary edema 
it induces; for McClean (43),  Olitsky and Schlesinger (44),  and  Sprunt  (20) 
have shown that procedures which produce local edema may result in increased 
infection of the skin with vaccinia and herpes viruses. Or, the action of urethane 
may depend on increased cellular permeability. Anselmino and Hoenig (45) 
have reported that urethane caused increased permeability of the cell membrane 
of erythrocytes. Boyd and Perry (46)  found that the bronchial secretions of 
urethanized cats contained 3 to 5 times as much potassium as those of decere- 
brate animals. This increase was accompanied by only a  slight fall of serum 
potassium and might reflect an increased permeability of the membranes of 
cells lining the respiratory tract. 
Finally, the possibility should be considered that urethane might mediate 
its effects on PVM indirectly by stimulating the adrenal glands. Murphy and 
Sturm (24) found the adrenal glands of rats given urethane to be 40 per cent 
larger than normal and we have observed, as described elsewhere (47),  that 
the adrenal cortical steroids may enhance the severity of PVIVI infection in 
mice. 
SD-MM.AR¥ 
Urethane,  given parenterally or orally to mice,  increased the  severity of 
PVM infection. Not only were the lesions more extensive but mice could be 
infected with smaller inocula of virus and the multiplication of virus in the 
lung was enhanced. There was atrophy of lymphoid tissues but no suppression 
was noted of antibody formation. No relation could be found between PVM 
infection and the development of pulmonary adenomas in mice. MIRICK~ SMITH~ LEFTWICH~ AND  LEFTWICH  159 
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